Terms: = Liver cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911
171 results:
1. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
3. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
4. An Evaluation Analysis for Computed Tomography Image Quality of Primary liver cancer Lesions Based on Deep Learning Image Reconstruction.
Sun Y; Sun DZ; Han CL
Curr Med Imaging; 2024; 20():1-6. PubMed ID: 38389358
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and health risk assessment of hydrogen cyanide and multi-mycotoxins in Nigerian garri.
Olorunnado GB; Muhammad HK; Apeh DO; Salubuyi S; Akanya HO; Gbashi S; Kumphanda J; Njobeh PB; Makun HA
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2024 Apr; 41(4):410-423. PubMed ID: 38315775
[TBL] [Abstract] [Full Text] [Related]
6. Thermal ablation versus liver resection for hepatocellular carcinoma in patients with cirrhosis: a systematic review and meta-analysis of propensity-score matched studies.
Wei Q; Xiong S; Luo W; Liang M; Luo B
Clin Exp Med; 2024 Feb; 24(1):32. PubMed ID: 38300338
[TBL] [Abstract] [Full Text] [Related]
7. cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation a radiomics nomogram for predicting thymidylate synthase status in hepatocellular carcinoma based on Gd-DTPA contrast enhanced MRI.
Ding Z; Wu Y; Fang G; Lin Z; Lin K; Fu J; Huang Q; Tang Y; You W; Liu J; Zeng Y
BMC Cancer; 2023 Oct; 23(1):991. PubMed ID: 37848807
[TBL] [Abstract] [Full Text] [Related]
9. Effect of conditions being present at time of surgery (PATOS) on outcomes in liver surgery.
Jehan FS; Ganguli S; Saif A; Hase NE; Nayak PS; Nayyar A; Aziz H
Am J Surg; 2024 Feb; 228():213-217. PubMed ID: 37839957
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis.
Li H; Zhang X; Zhao W; Cai F; Qin J; Tian J
BMC Cancer; 2023 Oct; 23(1):970. PubMed ID: 37828491
[TBL] [Abstract] [Full Text] [Related]
11. Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Lin W; Lu L; Zheng R; Yuan S; Li S; Ling Y; Wei W; Guo R
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17231-17239. PubMed ID: 37801135
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved.
Wang J; Liu F; Ma W; Hu H; Li F
Langenbecks Arch Surg; 2023 Sep; 408(1):382. PubMed ID: 37770780
[TBL] [Abstract] [Full Text] [Related]
13. Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study.
Ning Z; Xie L; Yan X; Hua Y; Shi W; Lin J; Xu L; Meng Z
Br J Radiol; 2023 Oct; 96(1150):20230079. PubMed ID: 37660471
[TBL] [Abstract] [Full Text] [Related]
14. Circular RNA SMARCA5 Promotes a Poor Prognosis and Radiotherapy Resistance for Patients with Hepatocellular Carcinoma.
Chang Z; Song Y; Luo F; Yang X; Cai Y; Guo H
Ann Clin Lab Sci; 2023 Jul; 53(4):573-577. PubMed ID: 37625840
[TBL] [Abstract] [Full Text] [Related]
15. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8
Winkler F; Hipp AV; Ramirez C; Martin B; Villa M; Neuwirt E; Gorka O; Aerssens J; Johansson SE; Rana N; Llewellyn-Lacey S; Price DA; Panning M; Groß O; Pearce EL; Hermann CM; Schumann K; Hannibal L; Neumann-Haefelin C; Boettler T; Knolle P; Hofmann M; Wohlleber D; Thimme R; Bengsch B
Gut; 2023 Oct; 72(10):1971-1984. PubMed ID: 37541771
[TBL] [Abstract] [Full Text] [Related]
16. The Impact of Sedation on Cardio-Cerebrovascular Adverse Events after Surveillance Esophagogastroduodenoscopy in Patients with Gastric cancer: A Nationwide Population-Based Cohort Study.
Kim SY; Lee JK; Lee KH; Jang JY; Kim BW;
Gut Liver; 2024 Mar; 18(2):245-256. PubMed ID: 37317513
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma.
Gharzai LA; Wang C; Tang M; Jackson WC; Maurino C; Cousins MM; Mendiratta-Lala M; Parikh ND; Mayo CS; Haken RKT; Owen D; Cuneo KC; Schipper MJ; Lawrence TS
Pract Radiat Oncol; 2023; 13(6):e504-e514. PubMed ID: 37295727
[TBL] [Abstract] [Full Text] [Related]
18. Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases.
IJzerman NS; Filipe WF; Bruijn P; Buisman FE; Doorn LV; Doornebosch PG; Holster JJ; Grootscholten C; Grünhagen DJ; van Bommel CPE; Homs MYV; Kok NFM; Verhoef C; Koerkamp BG; Kuhlmann KFD; Mathijssen RHJ; Koolen SLW
Biomed Pharmacother; 2023 Jun; 162():114625. PubMed ID: 37058821
[TBL] [Abstract] [Full Text] [Related]
19. CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B.
Chon HY; Lee HA; Park SY; Seo YS; Kim SG; Lee CH; Lee TH; Ahn SH; Wong VW; Yip TC; Liang LY; Kim IH; Wong GL; Kim SU
J Dig Dis; 2023 Feb; 24(2):113-121. PubMed ID: 37057685
[TBL] [Abstract] [Full Text] [Related]
20. Insights into synchronous peritoneal metastases from hepatobiliary origin: Incidence, risk factors, treatment, and survival from a nationwide database.
Rijken A; Bakkers C; Klümpen HJ; van der Geest LG; de Vos-Geelen J; van Erning FN; de Hingh IHJT
Eur J Surg Oncol; 2023 Aug; 49(8):1436-1443. PubMed ID: 36898900
[TBL] [Abstract] [Full Text] [Related]
[Next]
